DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

MyNewOptions: An Online Study of Reproductive Life Planning and Contraceptive Action Planning

Information source: Milton S. Hershey Medical Center
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Contraceptive Use; Unintended Pregnancy

Intervention: Reproductive Life Planning (RLP) (Behavioral); Contraceptive Action Planning (Behavioral); Contraception information (Behavioral)

Phase: N/A

Status: Active, not recruiting

Sponsored by: Milton S. Hershey Medical Center

Official(s) and/or principal investigator(s):
Cynthia H Chuang, MD, MSc, Principal Investigator, Affiliation: Penn State College of Medicine


The purpose of this web-based study is to determine whether reproductive life planning (RLP), with or without contraceptive action planning (RLP+), will result in reduced risk of unintended pregnancy when compared to an information-only control group.

Clinical Details

Official title: Reducing Unintended Pregnancies Through Reproductive Life Planning and Contraceptive Action Planning

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention

Primary outcome: contraceptive use

Secondary outcome:

effectiveness of contraceptive method

contraceptive method satisfaction

contraceptive self-efficacy

continuity of contraceptive use

contraceptive adherence

Detailed description: Most US families want 2 children, resulting in the average woman spending 3 decades of her life trying to avoid pregnancy. However, most women have at least one unintended pregnancy, resulting in 1. 5 million abortions and 1. 7 million unintended births annually. Women and couples try to avoid unintended pregnancy for a range of personal, social, and economic reasons, but also due to the increased physical and mental health effects for children that result from unintended pregnancy. Healthcare reform now requires that private health insurance companies cover all FDA-approved contraceptive methods with no copays or deductibles to the patient, creating a great opportunity for women with health insurance to get contraceptive methods they previously could not afford. In this study, women with health insurance will be randomly assigned to one of three groups: (1) Reproductive Life Planning (RLP)—women will complete a reproductive life plan that guides them to think about if and when they would want any future pregnancies, and to determine what contraceptive method(s) are best suited to them; (2) Reproductive Life Planning Plus (RLP+) which additionally includes "if-then planning," where women determine what they will do when they encounter difficult situations that make it difficult to use their contraceptive method perfectly; or (3) an information-only control group. The online format of the study allows for the potential of wide dissemination. The RLP and RLP+ interventions are expected to result in greater likelihood of contraceptive use, continuity of contraceptive use, and contraceptive adherence, and thus reduce overall risk of unintended pregnancy.


Minimum age: 18 Years. Maximum age: 40 Years. Gender(s): Female.


Inclusion Criteria:

- not currently pregnant

- sexually active with a male partner in the past 6 months OR anticipate being sexually

active with a male partner in the next 6 months

- does not intend pregnancy in the next 12 months

- has Internet access and email address

Exclusion Criteria:

- tubal sterilization

- hysterectomy

- partner with vasectomy

Locations and Contacts

Penn State College of Medicine, Hershey, Pennsylvania 17033, United States
Additional Information

Starting date: April 2014
Last updated: October 31, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017